弗里德里希缺氧和相关糖尿病:针对线粒体功能障碍的治疗方法
Pichakacheri Sureshkumar1,2,3, Sidharth S Kumar1, Johny Cheriyan4
1Dr. Suresh's Diabcare India Diabetes Center, Calicut, Kerala 673017, India.
JCEM case reports
|September 29, 2025
概括
线粒体类药物可以改善弗里德里希患者的血糖控制和神经症状.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 线粒体医学 线粒体医学
背景情况:
- 弗里德里希缺血症 (FA) 是一种罕见的遗传性神经退行性疾病.
- 患有FA的患者经常患上糖尿病 (DM),使管理复杂化.
- 线粒体功能障碍与FA病原和胰岛素耐药性有关.
研究的目的:
- 报告一个FA病例与非最佳管理的DM.
- 评估针对线粒体功能的治疗策略,以改善血糖控制和FA症状.
- 评估线粒体类药物在治疗同时存在的FA和DM中的作用.
主要方法:
- 一名患有FA和DM的32岁女性患者接受了胰岛素,DPP-4抑制剂,神经变维生素和线粒体变剂 (L-carnitine,CoQ10,维生素E,Imeglimin) 的治疗.
- 治疗疗效通过血糖稳定性,C-水平以及国际合作性性病评级表 (ICARS) 来监测.
主要成果:
- 在3-4个月内达到血糖稳定.
- 禁食C-水平在3年随访期间下降.
- ICARS评分从85提高到71,表明神经功能损害减少.
结论:
- 线粒体类药物在治疗患有DM的FA患者中显示出潜在的潜力.
- 这种方法可以增强胰岛素敏感性并减轻神经退行.
- 需要进一步的研究来证实特定药物的有效性,以改善代谢和神经系统的结果.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
ATP Synthase: Mechanism
16.7K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.7K


